nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—AVPR2—urine—polycystic ovary syndrome	0.13	0.486	CbGeAlD
Tolvaptan—AVPR1A—adrenal gland—polycystic ovary syndrome	0.0301	0.112	CbGeAlD
Tolvaptan—AVPR2—adipose tissue—polycystic ovary syndrome	0.0278	0.104	CbGeAlD
Tolvaptan—AVPR1A—endocrine gland—polycystic ovary syndrome	0.0261	0.0973	CbGeAlD
Tolvaptan—CYP3A4—urine—polycystic ovary syndrome	0.0199	0.074	CbGeAlD
Tolvaptan—ABCB1—embryo—polycystic ovary syndrome	0.00454	0.0169	CbGeAlD
Tolvaptan—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00372	0.0139	CbGeAlD
Tolvaptan—ABCB1—endometrium—polycystic ovary syndrome	0.00332	0.0124	CbGeAlD
Tolvaptan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00329	0.0123	CbGeAlD
Tolvaptan—ABCB1—uterus—polycystic ovary syndrome	0.00306	0.0114	CbGeAlD
Tolvaptan—ABCB1—pituitary gland—polycystic ovary syndrome	0.00301	0.0112	CbGeAlD
Tolvaptan—ABCB1—adipose tissue—polycystic ovary syndrome	0.003	0.0112	CbGeAlD
Tolvaptan—ABCB1—adrenal gland—polycystic ovary syndrome	0.00269	0.01	CbGeAlD
Tolvaptan—ABCB1—female gonad—polycystic ovary syndrome	0.00251	0.00934	CbGeAlD
Tolvaptan—Renal impairment—Metformin—polycystic ovary syndrome	0.0025	0.0617	CcSEcCtD
Tolvaptan—ABCB1—vagina—polycystic ovary syndrome	0.00249	0.00929	CbGeAlD
Tolvaptan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00244	0.0602	CcSEcCtD
Tolvaptan—ABCB1—endocrine gland—polycystic ovary syndrome	0.00233	0.00869	CbGeAlD
Tolvaptan—Dehydration—Metformin—polycystic ovary syndrome	0.00221	0.0546	CcSEcCtD
Tolvaptan—Breast disorder—Metformin—polycystic ovary syndrome	0.00215	0.0531	CcSEcCtD
Tolvaptan—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00162	0.0399	CcSEcCtD
Tolvaptan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00153	0.0377	CcSEcCtD
Tolvaptan—Angiopathy—Metformin—polycystic ovary syndrome	0.00149	0.0368	CcSEcCtD
Tolvaptan—Immune system disorder—Metformin—polycystic ovary syndrome	0.00149	0.0367	CcSEcCtD
Tolvaptan—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00148	0.0366	CcSEcCtD
Tolvaptan—Malnutrition—Metformin—polycystic ovary syndrome	0.00143	0.0354	CcSEcCtD
Tolvaptan—Dysgeusia—Metformin—polycystic ovary syndrome	0.0014	0.0346	CcSEcCtD
Tolvaptan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00133	0.0328	CcSEcCtD
Tolvaptan—Malaise—Metformin—polycystic ovary syndrome	0.00129	0.0319	CcSEcCtD
Tolvaptan—Syncope—Metformin—polycystic ovary syndrome	0.00129	0.0317	CcSEcCtD
Tolvaptan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00126	0.0311	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00121	0.0299	CcSEcCtD
Tolvaptan—Discomfort—Metformin—polycystic ovary syndrome	0.00121	0.0297	CcSEcCtD
Tolvaptan—Shock—Metformin—polycystic ovary syndrome	0.00115	0.0284	CcSEcCtD
Tolvaptan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00115	0.0283	CcSEcCtD
Tolvaptan—Skin disorder—Metformin—polycystic ovary syndrome	0.00114	0.028	CcSEcCtD
Tolvaptan—Anorexia—Metformin—polycystic ovary syndrome	0.00112	0.0275	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00102	0.00147	CbGpPWpGaD
Tolvaptan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00102	0.0251	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00101	0.00146	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00101	0.0249	CcSEcCtD
Tolvaptan—Constipation—Metformin—polycystic ovary syndrome	0.001	0.0247	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000998	0.00144	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000992	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000991	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000986	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000984	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000979	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000975	0.00141	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000975	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000974	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000971	0.0014	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000967	0.0014	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000964	0.0238	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000964	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000964	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000957	0.00138	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000924	0.00134	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000918	0.00133	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000915	0.00132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000915	0.00132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000908	0.00131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000908	0.00131	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000892	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000882	0.00128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000875	0.00127	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000861	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000856	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000855	0.00124	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000851	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00085	0.00123	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00084	0.00121	CbGpPWpGaD
Tolvaptan—Asthenia—Metformin—polycystic ovary syndrome	0.000839	0.0207	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000831	0.0012	CbGpPWpGaD
Tolvaptan—Pruritus—Metformin—polycystic ovary syndrome	0.000828	0.0204	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000825	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000808	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000802	0.00116	CbGpPWpGaD
Tolvaptan—Diarrhoea—Metformin—polycystic ovary syndrome	0.000801	0.0197	CcSEcCtD
Tolvaptan—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000797	0.00115	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000791	0.00114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000788	0.00114	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000782	0.00113	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000781	0.00113	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000774	0.00112	CbGpPWpGaD
Tolvaptan—Dizziness—Metformin—polycystic ovary syndrome	0.000774	0.0191	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000749	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000743	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000735	0.00106	CbGpPWpGaD
Tolvaptan—Headache—Metformin—polycystic ovary syndrome	0.000733	0.0181	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00073	0.00106	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000726	0.00105	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000717	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000712	0.00103	CbGpPWpGaD
Tolvaptan—Nausea—Metformin—polycystic ovary syndrome	0.000695	0.0171	CcSEcCtD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00069	0.000998	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00067	0.000969	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000665	0.000962	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000659	0.000953	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000656	0.000949	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000651	0.000942	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000651	0.000942	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000647	0.000935	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000641	0.000928	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00063	0.000911	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000626	0.000905	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000625	0.000904	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000624	0.000903	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000618	0.000894	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000613	0.000886	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000608	0.00088	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000601	0.000869	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000597	0.000864	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000594	0.000859	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FST—polycystic ovary syndrome	0.000593	0.000857	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00059	0.000853	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000589	0.000852	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000585	0.000847	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000583	0.000843	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000578	0.000837	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000569	0.000824	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000565	0.000818	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000552	0.000798	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00055	0.000796	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000548	0.000792	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000546	0.00079	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000546	0.00079	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000542	0.000784	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000539	0.00078	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000535	0.000774	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000529	0.000766	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000521	0.000753	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000517	0.000748	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000517	0.000748	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000512	0.00074	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000508	0.000735	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000508	0.000734	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000507	0.000734	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000505	0.000731	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000505	0.00073	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000504	0.000729	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000503	0.000728	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.0005	0.000723	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000498	0.00072	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000496	0.000718	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000479	0.000693	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000474	0.000685	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00047	0.000681	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000467	0.000676	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000464	0.000671	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000447	0.000646	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000444	0.000642	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000443	0.000641	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000425	0.000614	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000422	0.00061	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000418	0.000605	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000415	0.0006	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000414	0.000599	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000414	0.000598	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000411	0.000594	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000409	0.000592	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000408	0.00059	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000391	0.000566	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000385	0.000556	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000385	0.000556	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000382	0.000552	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000382	0.000552	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000376	0.000544	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000371	0.000536	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000368	0.000532	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000367	0.000531	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000366	0.00053	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000364	0.000527	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000361	0.000523	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000358	0.000518	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000356	0.000515	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000355	0.000514	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000355	0.000514	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000354	0.000512	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000341	0.000494	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000341	0.000493	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000339	0.00049	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000337	0.000487	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000336	0.000486	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000336	0.000486	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000336	0.000486	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000334	0.000483	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000333	0.000482	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000333	0.000482	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000323	0.000468	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000321	0.000465	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000318	0.000461	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000316	0.000457	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00031	0.000449	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000308	0.000445	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000305	0.000441	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000295	0.000427	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000293	0.000424	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000284	0.00041	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000284	0.00041	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000281	0.000407	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000279	0.000404	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000276	0.000399	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000274	0.000396	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00027	0.00039	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000266	0.000385	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000264	0.000382	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000236	0.000342	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000235	0.00034	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000233	0.000336	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000231	0.000335	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—polycystic ovary syndrome	0.00023	0.000332	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000224	0.000324	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000224	0.000324	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000217	0.000314	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000214	0.00031	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000206	0.000299	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000205	0.000296	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000203	0.000294	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.0002	0.000289	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000199	0.000288	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000198	0.000286	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000197	0.000286	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—polycystic ovary syndrome	0.000196	0.000284	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000191	0.000277	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000191	0.000276	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000191	0.000276	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00019	0.000275	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00019	0.000274	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000188	0.000272	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000186	0.000269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000182	0.000263	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00018	0.000261	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000178	0.000258	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000175	0.000253	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000175	0.000253	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.00017	0.000246	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00017	0.000246	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000162	0.000235	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000162	0.000234	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000152	0.00022	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000151	0.000219	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000146	0.000212	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000145	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000145	0.000209	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000143	0.000206	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000138	0.0002	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000138	0.0002	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000132	0.000191	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000129	0.000186	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000125	0.000181	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000125	0.00018	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000124	0.000179	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000116	0.000167	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000115	0.000166	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000111	0.000161	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00011	0.000159	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000107	0.000155	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000105	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000103	0.000149	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000102	0.000147	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.6e-05	0.000139	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.45e-05	0.000137	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.33e-05	0.000135	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.9e-05	0.000129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—polycystic ovary syndrome	8.64e-05	0.000125	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—polycystic ovary syndrome	8.58e-05	0.000124	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.18e-05	0.000118	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.12e-05	0.000117	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.96e-05	0.000115	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.94e-05	0.000115	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.69e-05	0.000111	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.48e-05	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.07e-05	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.85e-05	9.91e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.68e-05	9.66e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.6e-05	9.55e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.36e-05	9.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.34e-05	9.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.27e-05	9.06e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.03e-05	8.72e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.92e-05	8.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.82e-05	8.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.62e-05	8.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.04e-05	7.29e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.9e-05	7.09e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.61e-05	6.67e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.56e-05	6.59e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.5e-05	6.5e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.47e-05	6.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.11e-05	5.95e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.92e-05	5.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.72e-05	5.37e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.46e-05	5.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.81e-05	4.06e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.77e-05	4.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.75e-05	3.99e-05	CbGpPWpGaD
